Merck's Shingles Vaccine Zostavax FDA Approved For Younger Patients
Links shared publicly online about this topic.
- 413total visits
Merck's Shingles Vaccine Zostavax FDA Approved For Younger Patients
Merck's Zostavax, a drug approved by the Food and Drug Administration (FDA) to assist in the prevention of shingles for people over 60, has now been approved for those born later and can now be pr
View full resource at medicalnewstoday.com
Tags: Vaccination, Shingles, Diet and Nutrition, Drug, FDA, Vaccine, Merck & Co.
Most Recently Shared on March 26, 2011 at 1:13 am By:
Merck's Shingles Vaccine Zostavax FDA Approved For Younger Patients http://t.co/uxT0ntL via @mnt_diseases #nurses #IVchat
Also Shared By:
Advertisement
MNT Health News
@mnt_healthnews
Merck's Shingles Vaccine Zostavax FDA Approved For Younger Patients http://mnt.to/3SLp #healthnews
1 year ago...